Loading company…
U-Ploid develops fertility treatments intended to improve egg cell quality for older women undergoing IVF.
Founded in 2024 and based in Oxford, UK, U-Ploid Biotechnologies develops treatments aimed at improving egg cell quality for women undergoing IVF in their mid-30s to 40s. The company raised an undisclosed amount of pre-seed funding from Blue Collective in January 2024. It plans to develop additional treatments and expand into Asia and Europe.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in